You have searched for "Recalibration programme"

Showing 1-5 of 5

Sort by: Newest | Oldest | Relevance

Analyst Reports 13 Apr 2017 | 1:22 AM Premium

HLIB Research retains Sell on Pharmaniaga

KUALA LUMPUR: Hong Leong Investment Bank (HLIB) Research is maintaining its Sell rating on Pharmaniaga and target price of RM4.29, based on FY18 price-to-earnings multiples of 15.6 times , which is in line with the international peers.